Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aerie Pharmaceuticals (NQ: AERI )

17.64 USD -0.28 (-1.56%)
Streaming Delayed Price Updated: 11:09 AM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 99,742
Open 18.14
Bid (Size) 17.62 (1)
Ask (Size) 17.66 (2)
Prev. Close 17.92
Today's Range 17.54 - 18.14
52wk Range 9.010 - 21.30
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aerie Pharmaceuticals to Participate in the 20th Annual Needham Virtual Healthcare Conference
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
Aerie Pharmaceuticals Announces Publication of Peer-Reviewed Paper Evaluating the Treatment Effect of Netarsudil on Outflow Function in Steroid-Induced Glaucoma
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases

Performance

YTD
+34.45%
+34.45%
1 Month
-14.24%
-14.24%
3 Month
+25.02%
+25.02%
6 Month
+53.52%
+53.52%
1 Year
+14.25%
+14.25%

More News

Read More
Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Dry Eye Innovation Showcase
From Business Wire News Releases
Aerie Pharmaceuticals to Participate in the Oppenheimer 31st Annual Virtual Healthcare Conference
From Business Wire News Releases
Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
From Business Wire News Releases
IHE's Underlying Holdings Could Mean 20% Gain Potential
Tags ETFs
From ETF Channel
Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
From Business Wire News Releases
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021
From Business Wire News Releases
Stocks With Rising Relative Strength: Aerie Pharmaceuticals
From Investor's Business Daily
Noteworthy Monday Option Activity: ANAB, AERI, THC
Tags Stocks
From Market News Video
Aerie Pharmaceuticals Receives European Commission Approval for Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.